A company competitiveness analysis, highlighting prominent ophthalmic drug contract manufacturers based on supplier strength
A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services, including developer information
An analysis of the various partnerships related to continuous manufacturing, which have been established since 2013
A company competitiveness analysis, highlighting prominent oligonucleotide manufacturers for research and diagnostic, and therapeutic applications
In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers.
Elaborate profiles of popular players that offer a wide range of in vitro ADME testing services (shortlisted on the basis of the company size).
This presents lucrative opportunities for contract research providers that offer services for this rapidly evolving class of pharmacological interventions.
TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors